Weight loss is having a renaissance thanks to Glucagon-like peptide 1 agonists (GLP1s). It’s in the news, on social media, and on reality TV. Patients, healthcare providers, payors, and entrepreneurs are scrambling to understand the science, the opportunity, the cost, and the consequences.
Join us for a fascinating panel discussion on the new era of weight loss on Tuesday, Feb 20 from 7:00 AM to 9:30 AM at the InterContinental Houston – Medical Center. If you can’t join us in-person, log on and catch this special session virtually. The panel portion will run from 7:30/7:45 AM – 9:15/9:30 AM. Panelists will discuss the impact of the GLP1 class of medications as they apply to medical weight management, including the challenges, benefits, insights, and unknowns as they relate to their respective roles and the opportunity to improve patients’ health and equality outcomes.
This event meets the requirements for 1.5 hours of ACHE Qualifying Education, which you self-report after logging in to your account at www.ache.org
